Results

Total Results: 1,650 records

Showing results for "factors".

121. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
     August 01, 2016 - Review The value of omega 3 fatty acids (n-3 FA) intake to improve cardiovascular outcomes and risk factors … • What is the relative efficacy of different n-3 FA on CVD outcomes and risk factors? … • What are the effects of potential confounders or interacting factors—such as plasma lipids, body … • How does the efficacy or association of n-3 FA on CVD outcomes and risk factors differ by source … What is the relative efficacy of different n-3 FA on CVD outcomes and risk factors?

122. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
     October 01, 2010 - This method ignores the randomized nature of the data and is subject to a variety of confounding factors … The investigators could choose adding no correction factors or exploring alternative correction factors … Investigators should note the difference between two types of study-level factors: (1) factors that … A meta-regression on summarized patient-level factors may be subject to ecological fallacy, 51 a … Whenever possible, study level factors, including subgroup factors, considered in meta-regressions

123. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
     October 01, 2010 - This method ignores the randomized nature of the data and is subject to a variety of confounding factors … The investigators could choose adding no correction factors or exploring alternative correction factors … Investigators should note the difference between two types of study-level factors: (1) factors that … A meta-regression on summarized patient-level factors may be subject to ecological fallacy, 51 a … Whenever possible, study level factors, including subgroup factors, considered in meta-regressions

124. Ch-7-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
     March 29, 2012 - all observed pretreatment variables thought to have some connection to the outcome, all known risk factors … Risk Factors We now let C 0 be one or more baseline covariates measured at time zero. … Conditioning on such risk factors is unnecessary to remove bias but can result in efficiency gains … (e.g., trust in the medical system), economic factors (e.g., ability to pay), and institutional factors … The other variable selection criteria based on all pretreatment covariates and risk factors do not

125. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
     April 01, 2007 - Data Elements The selection of data elements requires balancing such factors as their importance for … The motivating factors for participation at each level and the factors necessary to achieve retention … • Important exposures, risk factors, and mitigating (or protective) factors are identified and collected … , and mitigating or protective factors … • The role and impact of missing data and potential confounding factors have been explored.

126. Protocol Amendment - Safety of Vaccines 030413 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
     September 18, 2012 - For each AE associated with a particular vaccine, what are the risk factors for the AE (including age … For each AE associated with a particular vaccine, what are the risk factors for the AE (including age … Both patient factors (i.e., age and race) and vaccine factors (i.e., formulation, dosage, and timing … ) may be risk factors for potential AEs associated with vaccination. … (no unvaccinated group necessary, but must control for multiple factors in a regression analysis).

127. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
     March 13, 2012 - A number of negative prognostic factors (factors associated with increased risk of recurrence) have … The current system used to assess recurrence risk using the prognostic factors noted above (e.g., a … MSI testing is widely available and used along with clinical risk factors to help make decisions about … as analytic factors [such as reagents used].) … For articles that describe analytic validity: • Was information provided about preanalytic factors

128. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
     January 01, 2024 - To assess whether pairwise meta-analysis will be appropriate, we will consider population factors such … as comorbidities, intervention factors such as intervention dose and frequency, and whether outcomes … In considering network meta-analysis, we will evaluate how these factors are distributed across direct … Based on EPC guidance, the SOE rating will be uninfluenced by these factors. … Factors important to consider include the type or extent of surgery participants in included studies

129. Icd-Categories-Prevalence-Reimbursement Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
     January 01, 2011 - claims totaled $25.5 billion, more than 30 percent of which was for supplementary classification of factors … puerperium E-codes* Digestive system diseases 2006 200920082007 * Supplementary classification of factors … accounting for the five highest Medicare reimbursements were: (1) Supplementary classification of factors … with those with the highest total reimbursements overall, except for Supplementary classification of factors … signs, and ill-defined conditions $ billion 20.5 22.3 24.3 25.5 * Supplementary classification of factors

130. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
     November 09, 2011 - prevention of surgical items left inside patient (surgical safety)  Medication administration  Human factors … Numerous factors have been postulated, and in some cases shown, to influence the effectiveness of a … patient safety practice, including contexts (such as safety culture, external factors and implementation … - Safety Culture, Teamwork, Leadership - Structural Organizational Characteristics - External Factors … Measure high-priority contexts in the 4 domains a) External factors, such as regulatory requirements

131. Amended Protocol: Maternal and Childhood Outcomes Associated with the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
     October 01, 2020 - Does the association vary by participant factors such as: i. Age of the mother at delivery ii. … Does the association vary by participant factors such as: i. Age of the mother at delivery ii. … Synthesis of Qualitative Results: The qualitative evidence synthesis will provide contextual factors … We will consider important contextual factors, including population characteristics (e.g., WIC program … and WIC participant related factors) and intervention (and comparison group) characteristics that may

132. Musculoskeletal-Complaints-Tests-Children Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
     March 01, 2012 - A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile … Serum concentration of hyaluronan, IgM and IgA rheumatoid factors in a population based study of juvenile … Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared … Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. … Prevalence of IgM, IgA and IgG rheumatoid factors in juvenile rheumatoid arthritis.

133. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
     January 31, 2013 - atherosclerotic disease of the coronary vessels, it is not surprising that PAD shares similar risk factors … The management of risk factors (i.e., tobacco use, diabetes, LDL levels, and hypertension) is considered … The decision to attempt revascularization in patients with CLI is based on a combination of factors, … Does the effectiveness of treatments vary by subgroup (age, sex, race, risk factors, comorbidities, … Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories.

134. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
     September 29, 2010 - OR “referral” OR diagnosis OR “predictive value of tests” OR “reproducibility of results” OR “sex factors … ” OR “age factors” OR anxiety OR comorbidity) AND (“ ANA test” OR “FANA test” OR “antinuclear antibod … Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology. … ti,ab. 72 or/184-186 13 or/119-128 73 exp demography/ 14 exp Lupus Erythematosus, Systemic/ 74 age factors … / or "age of onset"/ 15 (JSLE or SLE or "lupus erythematosus").ti,ab. 75 sex factors/ 16 exp Pain/di

135. Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
     September 01, 2021 - longer-term outcomes, and evaluate how benefits and harms according to demographic, clinical, and technical factors … and harms; analyses were conducted to assess how the control type, duration of symptoms, and other factors … evaluate how benefits and harms varied in subgroups defined by demographic, clinical, or technical factors … duration of pain, PMMA volume, requirement for bone edema on magnetic resonance imaging (MRI), and other factors … psychiatric or medical comorbidities), or technical (dose, intensity, duration, frequency, techniques) factors

136. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
     March 01, 2012 - What other medical, injury or treatment factors (i.e. orthopaedic resident cases, time?) … Venous thromboembolism: risk factors for recurrence. … Maynard (2010a) and Decousus (2010) – factors associated with bleeding risk. … Factors Associated with Prolonged Wound Drainage (Patel 2007) • THA – Factors associated with a prolonged … These factors were considered when assessing the applicability of the evidence. Freda C.

137. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
     March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…

138. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
     May 02, 2025 - To assess whether pairwise meta-analysis will be appropriate, we will consider population factors such … as comorbidities, intervention factors such as intervention dose and frequency, and whether outcomes … In considering network meta-analysis, we will evaluate how these factors are distributed across direct … Based on EPC guidance, the SOE rating will be uninfluenced by these factors. … Factors important to consider include the type or extent of surgery participants in included studies

139. Health-Careassociated-Infections Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_executive.pdf
     November 01, 2012 - Which factors are associated with the effectiveness of quality improvement strategies, including, for … – External Societal or Regulatory Factors 4 Methods Input From Stakeholders This systematic review … and providing examples of how contextual factors were addressed in some of the studies. … Information was also sought on unintended consequences of QI strategies and contextual factors that … The factors that can confound the results of such quasi-experimental studies are well known.

140. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0319_06-17-2009.pdf
     January 01, 2009 - Therefore, it was decided that a technical brief to identify the contextual factors and the current